Benzofuran-7-carboxamide was identified as a novel scaffold of poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor. A series of compounds with various 2-substituents including (tertiary amino)methyl moieties substituted with aryl ring and aryl groups containing tertiary amines, were synthesized and biologically evaluated to elucidate the structure-activity relationships and optimize the potency. 2-[4-(Pyrrolidin-1-ylmethyl)phenyl]-benzofuran-7-carboxamide (42) was the most potent as an IC 50 value of 40 nM among those.
Introduction
Poly(ADP-ribose) polymerase-1 (PARP-1) is a nuclear enzyme activated in response to DNA damage, and investigated in a wide range of therapeutic areas. 1 The most promising two major areas are ischemia 2 and cancer 3 of the several therapeutic indications for PARP-1 inhibitors. Activated PARP catalyzes the transfer of ADP-ribose units from nicotinamide adenine dinucleotide (NAD + ) to nuclear acceptor proteins such as histones, topoisomerases, DNA polymerases, DNA ligases and PARP itself. There is a solid pharmacophore, the amide, for NAD + competitive inhibitors, even though a variety of structures. 4 Restricted bicyclic and tricyclic lactams including isoquinolinones, 5 phthalazinones, phenanthridones, pyrroloisoquinolinones, 6 containing the arylamide into another ring, showed a good activity, of which geometry would be beneficial for PARP-1 inhibitory potency. Additionally, the imidazole, imidazopyridine and indole carboxamides appeared, in which the imidazole and indole nitrogen formed intramolecular hydrogen bond with the amide NH, then a "pseudo ring", similar to the lactam. 7 In this study we synthesized and biologically evaluated the benzofuran-7-carboxamide derivatives as PARP-1 inhibitors.
We anticipated that the oxygen of benzofuran might have the role like nitrogen of imidazole to form H-bond with the 7-carboxamide NH (Fig. 1) .
Chemistry. 2-(Aminomethyl)benzofuran-7-carboxamides were synthesized starting from 2-hydroxybenzamide (Scheme 1). The (allyloxy)benzene 1 was obtained by O-alkylation of 2-hydroxybenzamide using (2-bromo)allyl bromide, then subsequent Claisen rearrangement 8 of 1 gave the compound 2 by heating under microwave in DMF for 20 min. The (bromoallyl)phenol was cyclized to 2-methylbenzofuran 3 using DBU in toluene. A bromination using NBS (1. equiv) afforded the monobromide 4, which was reacted with various amines to provide the 2-(aminomethyl)bezofuran-7-carboxamide derivatives 5-21.
The salicyladehyde 23a, which is one of the key starting material to prepare 2-phenylbenzofuran-7-carboxamide derivatives, was prepared by the formylation of 2-hydroxybenzoic acid using hexamethylene tetramine in acidic condition, 10 following the esterification of resulting 3-formyl (22a) and 5-formyl (22b) isomeric mixtures, and then separation from 5-formyl-2-hydroxybenzoate 23b (Scheme 2).
2-Phenylbenzofuran-7-carboxamides were synthesized by the reaction of salicyladehyde substituted with a 2-carbox- ylic ester 23a and methyl 2-bromophenylacetate with a 3-or 4-formyl group at benzene ring 28 or 29 (Scheme 3). 9 The bromination of (3-or 4-methylphenyl)acetate 24 or 25 using N-bromosuccinimide gave bromo-(3-or 4-dibromomethylphenyl)acetate 26 or 27, of which dibromomethyl group was oxidized to aldehyde 28 or 29 with silver nitrate (Scheme 3). 11 The reaction of salicylaldehyde 23a and 2-bromophenylacetates (28, 29) with K 2 CO 3 in DMF at 120 o C, afforded the 2-phenylbenzofuran compounds (30, 31) via a sequence of reactions including O-alkylation, ring closure and decarboxylation to form a benzofuran ring. The aldehyde group of 30 or 31 was further diversified to the various amines 34-39 by reductive amination. Benzofuran-7-carboxamides 40-45 were synthesized from carboxylic acids through acid chlorides.
Biological Evaluation. The inhibitory effects of synthesized compounds on PARP-1 were determined as IC 50 by the converting biotinylated NAD-based colorimetric assays in clear 384-well plates as previously reported. 12 The IC 50 value of a reference, phenanthridine-6(5H)-one was determined as 0.22 μM, which was reported as 0.30 μM.
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Results and Discussion
We synthesized and biologically evaluated a series of benzofuran-7-carboxamide derivatives to identify a novel scaffold of PARP-1 inhibitor. It was suggested that hydrophobic moiety, especially secondary and tertiary amines at a proper site increased the binding affinity and improve the pharmaceutical properties.
14 Several secondary and tertiary 2-aminomethyl compounds (5, 6, 9, and 11) exhibited moderate PARP-1 inhibitory activities (IC 50 < 1 μM), showing the possibility of benzofuran as a PARP-1 inhibitor core structure. Also, it was known that aryl groups substituted at the para position of nicotinamide generally improve the potency due to π-π interactions with tyrosine in PARP-1. 4 Then, we introduced the phenyl ring at the 4-position of piperazine, piperidine, and 5,6-dihydropyridine to optimize the activity (13) (14) (15) (16) (17) (18) (19) (20) (21) . The IC 50 values of 2-methoxyphenyl-(13), 2-chlorophenyl-(14), 3-methoxyphenyl- (15) , and 4-fluorophenyl-(16) piperazines were each 3.75, 1.65, 0.38, 0.26 μM, while the IC 50 value of 4-methylpiperazine (10) was 3.65 μM. The introduction of meta or para substituted phenyl ring at piperazine (15, 16) greatly improved the potency. But the ortho substituted phenylpiperazines (13, 14) showed decreased activities than meta or para substituted phenylpiperazines. The 4-(4-chlorophenyl), and 4-(4-methoxyphenyl)-5,6-dihyhydropyridine compounds (20, 21) also represented improved potency, around 0.2 μM of IC 50 values. Additionally, we investigated 2-arylbenzofurans containing tertiary amine (40-45). It was reported that the introduction of tertiary amine at phenyl ring might beneficial for activity through the interaction with polar residues of enzyme such as Asp766 and Glu763.
15 Those activities were not quite different from 2-aminomethyl compounds with aryl substituent (13) (14) (15) (16) (17) (18) (19) (20) (21) . The para substitution of (tertiary amino)-methyl moiety at phenyl ring demonstrated better activity than the meta substituted analogues. The compound 42 containing pyrrolidine showed the most potent activity (IC 50 = 40 nM) among this series of compounds. In this study, we found the potential of benzofuran as a novel scaffold of PARP-1 inhibitors. After further investigation on this scaffold including solubility and toxicity, we are continuously going to optimize both in vitro and in vivo activities.
Experimental Section
Chemistry. Melting points were determined on a capillary melting point apparatus and are uncorrected. Anhydrous solvents were dried by conventional methods. Reagents of commercial quality were used from freshly opened containers (1): To a solution of salicylamide (500 mg, 3.65 mmol) in DMF (3 mL) was added K 2 CO 3 (756 mg, 5.47 mmol) and 2,3-dibromopropene (0.57 mL, 5.47 mmol), and the reaction mixture was stirred at 120 o C for an hr. Water was added, and the mixture was extracted with ethyl acetate twice. The organic layer was washed with brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 1:1) to yield 1 as a pale yellow solid (806 mg, 86%). 2-Methylbenzofuran-7-carboxamide (3): To a solution of the compound 2 (4.77 g, 18.6 mmol) in toluene (25 mL) was added DBU (5.57 g, 37.3 mmol), and the reaction mixture was heated at reflux with stirring for an hr. After cooling, water was added, and the mixture was extracted with ethyl acetate twice. The organic layer was washed with brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 1:1) to yield 3 as a white solid (2.54 g, 78%). 2-Bromomethylbenzofuran-7-carboxamide (4): To a solution of the compound 3 (567 mg, 3.24 mmol) in CCl 4 (20 mL) was added N-bromosuccinimide (634 mg, 3.56 mmol) and 2,2-azobis(isobutyronitrile) (107 mg, 0.65 mmol), and the reaction mixture was heated at reflux with stirring for 20 min. After cooling, the mixture was filtered, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane: ethyl acetate = 2:1) to yield 4 as a pale yellow solid (641 mg, 78%). 
2-{[4-(3-Methoxyphenyl)piperazin-1-yl]methyl}benzo-furan-7-carboxamide (15):
The compound 15 was obtained as a pale yellow solid (73% yield) by the same procedure to prepare 5, except using 1-(3-methoxyphenyl)piperazine as a starting material instead of methylamine. 
The compound 20 was obtained as a pale yellow solid (36% yield) by the same procedure to prepare 5, except using 4-(4-chlorophenyl)-1,2.3,6-tetrahydropyridine as a starting material instead of methylamine. 15 mol) in acetic acid (300 mL) was added hexamethylenetetramine (40.6 g, 0.29 mol) and the reaction mixture was heated at reflux for 2 hr, following the addition of 33% H 2 SO 4 and continuous heating at reflux with stirring for an additional hour. After cooling, the mixture was extracted with diethyl ether 3 times. The organic layer was washed with H 2 O and then brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure. The compound was purified by recrystallization from methanol as a pale yellow solid. To the solution of compound 22a in methanol was added thionyl chloride and the reaction mixture was heated at reflux for 3 hr. After cooling, the mixture was concentrated under reduced pressure. To the residue was added H 2 O, which was extracted with ethyl acetate three times. The organic layer was washed with H 2 O and then brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 9:1) to yield 23a as an off white solid. (24): To the solution of 2-(ptolyl)acetic acid (10 g, 66.6 mmol) in methanol (120 mL) was added c-H 2 SO 4 (1.3 g, 13.32 mmol) and the reaction mixture was heated at reflux for 3 hr. After cooling, water was added, and the mixture was extracted with ethyl acetate twice. The organic layer was washed with brine, dried (MgSO 4 ), filtered, and concentrated under reduced pressure, to give the product as an oil (10.8 g, 99% crude yield), which was used for the nest step without purification.
Methyl 2-(m-tolyl)acetate (25): The compound 25 was obtained as an oil (87% yield) by the same procedure to prepare 24, except using 2-(m-tolyl)acetic acid as a starting material instead of 2-(p-tolyl)acetic acid. Methyl bromo-(3-dibromomethylphenyl)acetate (27): The compound 27 was obtained as an oil (95% yield) by the same procedure to prepare 26, except using the compound 25 as a starting material. Methyl 2-bromo-2-(4-formylphenyl)acetate (28): To the solution of AgNO 3 (4.4 g, 25.9 mmol) in H 2 O (50 mL), the compound 26 (5.2 g, 13.0 mmol) dissolved in ethanol (150 mL) was added at 100 o C. The reaction mixture was heated at reflux with stirring for 15 min, and then filtered after cooling. The filtrate was concentrated under reduced pressure. The residue was dissolved in ethyl acetate, washed with water and brine, dried (MgSO 4 ), filtered, and then concentrated under reduced pressure. The residue was purified by silica gel column chromatography (hexane:ethyl acetate = 9:1) to give the compound 28 as a pale yellow oil (2.9 g, 87% yield). 2-(4-Formylphenyl)benzofuran-7-carboxylic acid (32): To the solution of the compound 30 (5 g, 17.84 mmol) in methanol (50 mL) was added 2 N NaOH (13.4 mL), and the reaction mixture was heated at reflux for an hr. After cooling to rt, the reaction was diluted with water and acidified with HCl, which formed the off white precipitates. The precipitates were washed with H 2 O and ethyl acetate, then dried under vacuum to give a carboxylic acid as a white solid (4.0 g, 85%), which was used in next step without any purification. 2-(3-Formylphenyl)benzofuran-7-carboxylic Acid (33): The compound 33 was obtained as a white solid by the same procedure to prepare 32, starting from the compound 31 (80% yield). Preparation of 2-(aminomethylphenyl)benzofuran-7-carboxamide (40-45).
2-[4-(Piperidin-1-ylmethyl)phenyl]benzofuran-7-carboxamide (40): To the solution of the compound 32 (200 mg, 0.75 mmol) in dichloroethane was added piperidine (0.10 mL, 0.98 mmol) and acetic acid (0.06 mL, 0.98 mmol). The reaction mixture was stirred at rt for 2 hr, following the addition of NaBH(OAc) 3 (207 mg, 0.98 mmol), then continuously stirred for an additional 8 hr at rt. Water was added to the reaction, which was extracted with ethyl acetate twice. The organic extracts were washed with brine, dried (MgSO 4 ), filtered, concentrated under reduced pressure to give the carboxylic acid 34 as a yellow solid (85 mg), which was used in next step without any purification. To the solution of the carboxylic acid 34 (85 mg, 0.25 mmol) in dichloroethane was added SOCl 2 (0.06 mL, 0.76 mmol). The reaction mixture was stirred at rt for 3 hr, and concentrated under reduced pressure. The residue was dissolved in THF, then cooled to 0 °C, following the addition of ammonia water. The reaction mixture was stirred for an hr at rt, then water was add, which was extracted with ethyl acetate twice. The extracts were washed with brine, dried (MgSO 4 ), filtered, and concentrated under the reduced pressure. The residue was purified by silica gel column chromatography
